Search
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
In a Cannabis Business Times article, Partner Zachary Kobrin in Fort Lauderdale shared predictions for the newly legalized adult-use markets in Maryland and Missouri, as well as how the federal landscape may shift in the next year. On the topic of the SAFE Banking Act, Kobrin said it is “the most...
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
Zachary Kobrin spoke on a panel titled, “Mock Negotiation: Buying/Selling A License” at The Marijuana Business Conference (MJBizCon) Cannabis Law Sessions presented by The International Cannabis Bar Association (INCBA). This panel featured a mock negotiation of the purchase/sale of a cannabis...
Ruth Rauls, a Partner in the firm's Cannabis Practice, will participate as a speaker during the 2022 Rowan University Cannabis Forum: Assessing the Legalization of Cannabis in New Jersey on its Two-year Anniversary. Ruth's session will cover the implications of cannabis legislation on businesses and...
Ruth Rauls, a Partner in the firm's Cannabis Practice, will participate as a speaker during the Rowan University Cannabis Forum 2022: Assessing the Legalization of Cannabis in New Jersey on its Two-year Anniversary. Ruth's session is entitled "Implications of Cannabis Legislation on Businesses...
Jonathan Havens, Co-Chair of the firm's Cannabis Practice, will speak during the 2022 Tobacco/OTP + CBD Forum in Orlando, FL.
MAKING SENSE OF PRES. BIDEN’S CANNABIS REFORM STATEMENT – FDA’S ROLE IN SCHEDULING EVALUATION Jonathan Havens, Co-Chair of the firm's Cannabis Practice, will discuss President Biden’s recent cannabis reform announcement, its implications for various stakeholders, and FDA’s role in evaluating how...
GOOD MORNING CANNABIS: EPISODE 29 In this episode, we talk to Jonathan Havens, Co-Chair of Cannabis Law at Saul Ewing LLP, and discuss what those in the cannabis industry could expect during the midterm elections.
INTO THE RABBIT HOLE OF PSYCHEDELICS: EXPLORING MDMA, PSILOCYBIN, LSD, AYAHUASCA, DMT, IBOGAINE, KETAMINE, AND OTHER PSYCHEDELICS. Jonathan Havens, Co-Chair of the Firm's Cannabis Practice, will be speaking at the Psychedelic Medicine Conference/CBD Expo. Jonathan's panel will dive down the rabbit...
‘A Very Long and Hard-Fought Battle:’ Inside One Company’s Quest to Secure Licenses in Illinois’ Adult-Use Cannabis Market A court recently allowed High Haven to win five dispensary licenses in a corrective lottery. Now, the company is on a mission to secure a craft grow license. “The case against...
How a long-shot weed shop beat the odds: Crain's Daily Gist podcast Crain's reporter John Pletz talks with host Amy Guth about the marijuana industry, including a local company that beat long odds in a pot-shop license lottery and a court challenge.
Saul Ewing LLP represented High Haven , an Illinois-based cannabis company, in its challenge of the Illinois Department of Financial & Professional Regulation’s (“IDFPR”) decision to reject High Haven’s social equity application for cannabis dispensary licenses. As a result of IDFPR’s denial, High...
Jonathan Havens, Co-Chair of Saul Ewing's Cannabis Law Practice, will speak at The Cannabis and Psychedelics Investment Summit in London on September 20, 2022. Jonathan will be joining a panel entitled "A Legal Overview: The Future of Cannabis and Psychedelic Policy."